The future of medicine for Alzheimer’s and Parkinson’s diseases
4 years ago
Episode 27 – Using Artificial Intelligence to speed Alzheimer’s studies
This week, Shanti and Eliot talk to founder and CEO of Unlearn, Charles Fisher. They discuss how artificial intelligence can effect Alzheimer's drug research.